Regression of refractory intraocular large B-ce... [J Clin Oncol. 2011] - PubMed

Save items

loading

Related citations in PubMed

Higher response to lenalidomide in relapsed/refractory diffuse large B-cell lymphoma in nongerminal center B-cell-like than in germinal center B-cell-like phenotype. [Cancer. 2011]
Higher response to lenalidomide in relapsed/refractory diffuse large B-cell lymphoma in nongerminal center B-cell-like than in germinal center B-cell-like phenotype.
Hernandez-Ilizaliturri FJ, Deeb G, Zinzani PL, Pileri SA, Malik F, Macon WR, Goy A, Witzig TE, Czuczman MS. Cancer. 2011 Nov 15; 117(22):5058-66. Epub 2011 Apr 14.
An international phase II trial of single-agent lenalidomide for relapsed or refractory aggressive B-cell non-Hodgkin's lymphoma. [Ann Oncol. 2011]
An international phase II trial of single-agent lenalidomide for relapsed or refractory aggressive B-cell non-Hodgkin's lymphoma.
Witzig TE, Vose JM, Zinzani PL, Reeder CB, Buckstein R, Polikoff JA, Bouabdallah R, Haioun C, Tilly H, Guo P, et al. Ann Oncol. 2011 Jul; 22(7):1622-7. Epub 2011 Jan 12.
Lenalidomide monotherapy in relapsed or refractory aggressive non-Hodgkin's lymphoma. [J Clin Oncol. 2008]
Lenalidomide monotherapy in relapsed or refractory aggressive non-Hodgkin's lymphoma.
Wiernik PH, Lossos IS, Tuscano JM, Justice G, Vose JM, Cole CE, Lam W, McBride K, Wride K, Pietronigro D, et al. J Clin Oncol. 2008 Oct 20; 26(30):4952-7. Epub 2008 Jul 7.
Review New developments in the management of diffuse large B-cell lymphoma. [Hematology. 2012]
Review New developments in the management of diffuse large B-cell lymphoma.
Habermann TM. Hematology. 2012 Apr; 17 Suppl 1:S93-7.
Review HIV-related lymphoma treated with maintenance thalidomide. [Clin Adv Hematol Oncol. 2005]
Review HIV-related lymphoma treated with maintenance thalidomide.
Larson ML, Enschede SH, Gregory SA. Clin Adv Hematol Oncol. 2005 Mar; 3(3):231-4; discussion 234-5.

See reviews... See all...

Cited by 1 PubMed Central article

High-dose chemotherapy and autologous stem cell transplantation for secondary central nervous system lymphoma: many are called, but few are chosen. [Haematologica. 2013]
High-dose chemotherapy and autologous stem cell transplantation for secondary central nervous system lymphoma: many are called, but few are chosen.
Abramson JS. Haematologica. 2013 May; 98(5):662-4.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Regression of refractory intraocular large B-cell lymphoma with lenalidomide mon...
Regression of refractory intraocular large B-cell lymphoma with lenalidomide monotherapy.
J Clin Oncol. 2011 Jul 10 ;29(20):e595-7. doi: 10.1200/JCO.2011.34.7252. Epub 2011 Apr 25 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

Regression of refractory intraocular large B-cell lymphoma with lenalidomide monotherapy.

Source

Publication Types, MeSH Terms, Substances, Grant Support

Publication Types

MeSH Terms

Substances

Grant Support

LinkOut - more resources

Full Text Sources

Medical

Molecular Biology Databases

Supplemental Content

Save items

Related citations in PubMed

Cited by 1 PubMed Central article

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information